Objective: To compare the duration of birth hospitalization in mothers with multiple sclerosis (MS) and their newborns relative to the general population and to investigate the impact of MS-related clinical factors on the length of birth hospitalization stays.
Multiple sclerosis (MS) is a chronic degenerative disease of the CNS, often manifesting in women of childbearing age. 1 Fatigue and pelvic organ dysfunction are common, 2 which may cause difficult labor and prolonged birth hospitalization. MS has been associated with a greater risk of difficult labor, 3 assisted vaginal delivery, 3 cesarean delivery, 4 as well as impaired fetal growth and prematurity. [3] [4] [5] [6] Although not all agree, more recent studies found no link between MS and adverse perinatal outcomes. [7] [8] [9] [10] However, the durations of birth hospitalization were not examined in these studies. To our knowledge, only 2 studies have examined birth hospitalization in MS 4, 11 ; both were from the United States and reported longer hospital stays for mothers with MS 4, 11 and their newborns 11 compared with the general population. Prolonged stays can have negative consequences, including an increased risk of hospital-acquired infection as well as creating a strain on scarce health care resources. 12 By linking 2 comprehensive population databases, the British Columbia Multiple Sclerosis (BCMS) database and the British Columbia Perinatal Database Registry (BCPDR), we set out to validate earlier observations regarding the length of birth hospitalization for mothers with MS and their newborns, relative to the general population, as well as explore any association with MS clinical factors.
METHODS Data sources. The BCMS database contains clinical data collected since September 1980 (when the first British Columbia [BC] MS clinic opened) for an estimated 80% of MS patients in BC. 13, 14 MS specialist neurologists generated the data for this study, which were collected from 4 MS clinics in BC (Kelowna, Prince George, Vancouver, and Victoria). The BCPDR, a province-wide database overseen by Perinatal Services BC, contains pregnancy data recorded at prenatal visits as well as at the time of birth. Data collection began in 1994 with full provincial coverage established in April 2000. The BCPDR is estimated to capture more than 99% of births reaching at least 20 weeks' gestation. 15 The BCMS database and BCPDR are reliable and objective sources of data, being collected largely in a prospective manner by trained health care professionals without a specific research question in mind. For this current study, birth hospitalization data collected up to March 31, 2009 were used.
Study participants. This cohort of mothers and newborns has been described previously. 7 Briefly, births were classified as "births to MS mothers" if women had a neurologist-confirmed diagnosis of laboratory-supported or clinically definite MS (Poser 16 or McDonald 17 criteria) with disease onset before delivery. Birth hospitalization data of MS mothers were obtained by linking the BCMS database to the BCPDR at the individual level via the Personal Health Number, a unique identifier assigned to all residents of BC, verified by maternal names and dates of birth. Birth hospitalization data from the general population were obtained from a frequency-matched sample of births matched by maternal age (61 year), local health authority, and delivery year. We excluded births occurring before onset of MS. We also excluded non-singleton births (i.e., twins and triplets) because of associated complications that could prolong the length of birth hospitalization. Pregnancies ending before 20 weeks' gestation were not available.
Demographics, clinical characteristics, and outcomes. Maternal characteristics included the following: age; body mass index (BMI); gravidity; parity; number of antenatal visits; lone parent status; alcohol, drug, and cigarette use (as identified by a physician or midwife as a risk during pregnancy); hypertension (preexisting, gestational, or preeclampsia); abnormal serum glucose levels or diabetes (preexisting or identified during pregnancy); duration of the second stage of labor; assisted vaginal delivery (forceps and/or vacuum extraction); and cesarean delivery. Newborn characteristics included birth weight, gestational age, 5-minute Apgar score, and congenital anomalies. MS clinical characteristics included disease course (relapsingonset, primary progressive, or unknown), age at MS onset, disease duration, and level of disability around the time of delivery (63 years) as measured by the Expanded Disability Status Scale (EDSS) score. 18 Primary outcomes were the length of maternal and neonatal hospitalization related to delivery. Secondary outcomes included neonatal intensive care unit (NICU) admission rates and length of stay in the NICU.
Statistical analyses. Maternal and newborn characteristics were compared between births and mothers with MS and the general population using the x 2 test or Fisher exact test for categorical variables and the Mann-Whitney U test for continuous variables. The generalized estimating equations approach was used to account for multiple singleton births to the same mother (clustering effects) and confounders. In building the generalized estimating equations, a logarithmic transformation was applied to the length of birth hospitalization to account for the right-skewed data distribution. A priori potential confounders considered in the maternal hospitalization analysis included cesarean delivery, 19, 20 maternal age, 19 maternal comorbidity 19 (hypertension or diabetes), number of antenatal visits, 19 obesity as measured by BMI, 21 parity, 19 and prolonged labor. 19 For newborns, the following a priori confounders were considered: 5minute Apgar score, 19 birth weight, 19 congenital anomaly, 19 maternal age, 19 comorbidity 19 (hypertension or diabetes), and substance use exposure 19 (i.e., alcohol, cigarettes, or drugs of abuse). When data on confounders were unavailable for .20% of the MS cohort (i.e., BMI and duration of the second stage of labor), the effect of including, then excluding, each variable was examined; where no significant effect on the outcome was found, then the confounder(s) was excluded from the final model. In addition, because any adverse event affecting the duration of newborn hospitalization was deemed a potential factor in the causal pathway affecting the duration of maternal hospitalization 22 and vice versa, the newborn's duration of hospitalization was not included as a potential confounder when examining the mother's duration of stay (and vice versa). Propensity score (PS) matching was used as an additional means of balancing the MS and general population cohorts, as outlined in appendix e-1 on the Neurology ® Web site at www.neurology.org. In the analysis of MS mothers, MS disease duration was included as a continuous variable, with disability categorized into 4 groups: EDSS score of 0 (normal neurologic exam), 1.0 to 1.5 (no disability but minimal neurologic symptoms present), 2.0 to 2.5 (minimal disability), and $3.0 (mild to moderate disability or higher). 18 Associations between MS (as well as disease duration and disability) and birth hospitalization on the logarithm scale were reported with regression coefficients (b), 95% confidence interval (CI) and p values. Admissions to the NICU were reported descriptively only. All reported p values were 2-sided with an a of 0.05. Statistical analyses were conducted using SPSS 17.0 (IBM, Armonk, NY) with R (version 2.15.1) used for the PS matching.
Standard protocol approvals, registrations, and patient consents. The University of British Columbia's Clinical Research
Ethics Board and the Vancouver Coastal Health Research Institute approved the study, which involved informed consent.
RESULTS Demographics and clinical characteristics.
Linkage of 7,056 female patients in the BCMS database to pregnancy data from the BCPDR identified 762 births to 550 women with MS. A frequency-matched sample of 3,048 births from the general population was selected for comparison. Non-singleton infants (n 5 101), births to mothers without a diagnosis of clinically definite MS (n 5 225), or mothers with MS onset after delivery (n 5 76) were excluded, resulting in 432 births to 321 women with MS and 2,975 births to 2,958 women from the general population. In this cohort, women with MS had 1 stillbirth whereas the sample of women in the general population had 16 stillbirths. The cohort characteristics have been previously reported 7 and are summarized in table 1. Women in the MS group were more likely to be first-time mothers, hypertensive, nondiabetic, to smoke cigarettes during pregnancy, have a higher BMI, attend more antenatal visits, and have a longer duration of the second stage of labor. All other characteristics were comparable (table 1) .
The majority of MS women had relapsing-onset MS, of which 18 births were to women with secondary progressive MS. Other clinical characteristics of the MS cohort (age at MS onset, disease duration, EDSS score) are provided in table 2.
Birth hospitalization. After accounting for clustering (multiple singleton births to the same mother) and confounding, the difference in length of maternal hospitalization on the logarithm scale was not statistically or clinically significant for mothers with MS (median difference of 11.5 hours) compared with the general population (table 3) . Predictors of a longer length of maternal hospitalization in this sample of births in BC included older maternal age (p 5 0.03), primiparity (giving birth for the first time) (p , 0.001), cesarean delivery (p , 0.001), and presence of hypertension (p 5 0.047). In contrast, the number of antenatal visits or presence of diabetes was not significantly associated with the length of maternal hospitalization (p . 0.05) (data not shown).
The duration of newborn hospitalization was also not significantly different between births to mothers with MS and the general population (median difference of 12.1 hours) (table 3) . Overall, a longer length of newborn hospitalization was significantly associated with lower birth weight (p , 0.001), lower 5-minute Apgar score (p , 0.001), presence of congenital anomaly (p 5 0.01), maternal hypertension (p 5 0.001), and cigarette (p 5 0.02) and drug use (p 5 0.003) identified as a risk during pregnancy, but not maternal age, diabetes, or alcohol use (p . 0.05) (data not shown).
Findings for both maternal and newborn hospitalizations remained virtually unchanged after PS matching (see tables e-1 to e-6).
No significant associations were found between length of maternal/newborn hospitalization and MS clinical factors (table 4) .
Admissions to NICU. Similar to the general population (n 5 53, 2%), a small proportion of newborns to mothers with MS (n 5 12, 3%) were admitted to the NICU after birth. The median length of stay for newborns in the NICU was 4.5 days (range: 1-16 days) to mothers with MS, and 2 days (range: 1-40 days) to mothers from the general population. DISCUSSION Mothers with MS and their newborns had a similar duration of birth hospitalization as the general population, in contrast with 2 other studies whose authors reported longer birth hospitalizations. 4, 11 The authors of one US study in Washington state concluded that mothers with MS (n 5 198) were more likely to have birth hospitalizations lasting 4 to 6 days (but not shorter [1-3 days] or longer [.6 days] stays) compared with the general population (relative risk 5 1.7; 95% CI: 1.2-2.6; adjusted for maternal age and delivery 19, 20 in women with MS when MS was identified by ICD billing codes alone 4 -something not found in other studies with a more comprehensive case ascertainment. 7 One study examining hospital stays in newborns of mothers with MS 11 reported longer stays (relative risk 5 1.5; 95% CI: 0.99-2.3) compared with newborns of mothers without MS 11 ; however, the authors speculated this was attributable to the common practice of discharging mother and newborn home together, as no other adverse birth outcomes were observed. Our study differed from previous studies 4,11 examining birth hospitalizations in a number of ways: first, our study included a cohort of women with clinically definite MS confirmed by an MS specialist neurologist, rather than relying on a single ICD code (a valid algorithm for MS requires multiple ICD billing codes recorded over a period of time) 23 to identify MS. Second, we found that the length of birth hospitalization in patients with MS was not associated with disease duration or level of disability, which was not previously examined. These findings should be considered exploratory in nature and require confirmation. Third, we were able to account for data clustering arising from consecutive births to the same mother and control for confounders not considered in previous studies. Failure to adjust for these important factors may over-or underestimate the true effect of MS on birth hospitalization. We also matched mothers with MS by delivery year and local health authority to a sample of mothers from the general population to minimize potential temporal and regional differences in birth discharge practices. Finally, findings remained virtually unchanged when PS matching was applied.
A potential limitation is that MS patients with mild disease and/or limited access to an MS clinic in BC because of geographic distance may not have been captured in our database. Women with MS had an EDSS score of less than 3.0 around the time of delivery in approximately 80% of births with an EDSS score available, making our study less applicable to women with higher MS disability. Nonetheless, our study is likely broadly representative of MS patients in BC and generalizable to populations of MS mothers in Western countries with a similar health care structure to Canada. Few newborns were admitted to the NICU (with a similar proportion being admitted in the MS and general population cohorts), such that we are unable to draw firm conclusions based on these data. Finally, factors such as parental ethnicity, parental perceptions of their childcare abilities, socioeconomic background, and the availability of support resources after discharge from hospital were not available, but could influence the length of birth hospitalization. 19 Overall, our findings are reassuring for women with MS planning a pregnancy or already expecting a child; the presence of MS in the mother does not seem to alter the length of birth hospitalization for the mother or baby. 
